Metal Springs
Metal Springs market is segmented by region (country), players, by Type and by Application. Playe ... Read More
Global and United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size for the Year 2017-2028
1.2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size for the Year 2017-2028
1.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Dynamics
1.4.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Trends
1.4.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
1.4.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
1.4.4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Type
2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Type
2.1.1 Delafloxacin
2.1.2 Vancomycin
2.1.3 Ceftaroline Fosamil
2.1.4 Others
2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017-2028)
2.4 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017-2028)
3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Application
3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Segment by Application
3.1.1 Cellulitis
3.1.2 Abscess
3.1.3 Surgical Wounds
3.1.4 Traumatic Wound
3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017-2028)
3.4 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017-2028)
4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Competitor Landscape by Company
4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Company
4.1.1 Top Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Player (2017-2022)
4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Concentration Ratio (CR)
4.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment in 2021
4.2.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Headquarters, Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Headquarters and Area Served
4.3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Company
4.5.1 Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region
5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2017-2028)
5.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region: 2017-2022
5.2.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Furiex Pharmaceuticals, Inc.
7.1.1 Furiex Pharmaceuticals, Inc. Company Details
7.1.2 Furiex Pharmaceuticals, Inc. Business Overview
7.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.1.5 Furiex Pharmaceuticals, Inc. Recent Development
7.2 GlaxoSmithKline plc
7.2.1 GlaxoSmithKline plc Company Details
7.2.2 GlaxoSmithKline plc Business Overview
7.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.2.5 GlaxoSmithKline plc Recent Development
7.3 Melinta Therapeutics, Inc.
7.3.1 Melinta Therapeutics, Inc. Company Details
7.3.2 Melinta Therapeutics, Inc. Business Overview
7.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.3.5 Melinta Therapeutics, Inc. Recent Development
7.4 Debiopharm International S.A.
7.4.1 Debiopharm International S.A. Company Details
7.4.2 Debiopharm International S.A. Business Overview
7.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.4.5 Debiopharm International S.A. Recent Development
7.5 MerLion Pharmaceuticals Pte Ltd.
7.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details
7.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview
7.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
7.6 Durata Therapeutics, Inc.
7.6.1 Durata Therapeutics, Inc. Company Details
7.6.2 Durata Therapeutics, Inc. Business Overview
7.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.6.5 Durata Therapeutics, Inc. Recent Development
7.7 Paratek Pharmaceuticals, Inc.
7.7.1 Paratek Pharmaceuticals, Inc. Company Details
7.7.2 Paratek Pharmaceuticals, Inc. Business Overview
7.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.7.5 Paratek Pharmaceuticals, Inc. Recent Development
7.8 Cempra, Inc.
7.8.1 Cempra, Inc. Company Details
7.8.2 Cempra, Inc. Business Overview
7.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.8.5 Cempra, Inc. Recent Development
7.9 Abbott Laboratories, Inc.
7.9.1 Abbott Laboratories, Inc. Company Details
7.9.2 Abbott Laboratories, Inc. Business Overview
7.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.9.5 Abbott Laboratories, Inc. Recent Development
7.10 Actelion Pharmaceuticals Ltd.
7.10.1 Actelion Pharmaceuticals Ltd. Company Details
7.10.2 Actelion Pharmaceuticals Ltd. Business Overview
7.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.10.5 Actelion Pharmaceuticals Ltd. Recent Development
7.11 Albany Molecular Research, Inc.
7.11.1 Albany Molecular Research, Inc. Company Details
7.11.2 Albany Molecular Research, Inc. Business Overview
7.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.11.5 Albany Molecular Research, Inc. Recent Development
7.12 Allergan plc.
7.12.1 Allergan plc. Company Details
7.12.2 Allergan plc. Business Overview
7.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.12.5 Allergan plc. Recent Development
7.13 AstraZeneca
7.13.1 AstraZeneca Company Details
7.13.2 AstraZeneca Business Overview
7.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.13.5 AstraZeneca Recent Development
7.14 Bayer AG
7.14.1 Bayer AG Company Details
7.14.2 Bayer AG Business Overview
7.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.14.5 Bayer AG Recent Development
7.15 Macrolide Pharmaceuticals, Inc.
7.15.1 Macrolide Pharmaceuticals, Inc. Company Details
7.15.2 Macrolide Pharmaceuticals, Inc. Business Overview
7.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.15.5 Macrolide Pharmaceuticals, Inc. Recent Development
7.16 Merck & Co, Inc.
7.16.1 Merck & Co, Inc. Company Details
7.16.2 Merck & Co, Inc. Business Overview
7.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.16.5 Merck & Co, Inc. Recent Development
7.17 Pfizer, Inc.
7.17.1 Pfizer, Inc. Company Details
7.17.2 Pfizer, Inc. Business Overview
7.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.17.5 Pfizer, Inc. Recent Development
7.18 Sanofi
7.18.1 Sanofi Company Details
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.18.5 Sanofi Recent Development
7.19 Teva Pharmaceuticals Industries Ltd.
7.19.1 Teva Pharmaceuticals Industries Ltd. Company Details
7.19.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.19.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.19.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.19.5 Teva Pharmaceuticals Industries Ltd. Recent Development
7.20 Zavante Therapeutics, Inc.
7.20.1 Zavante Therapeutics, Inc. Company Details
7.20.2 Zavante Therapeutics, Inc. Business Overview
7.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
7.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
7.20.5 Zavante Therapeutics, Inc. Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Trends
Table 3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
Table 4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
Table 5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints
Table 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Player, 2017-2022
Table 13. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2021)
Table 15. Top Players of Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Furiex Pharmaceuticals, Inc. Company Details
Table 31. Furiex Pharmaceuticals, Inc. Business Overview
Table 32. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 33. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 34. Furiex Pharmaceuticals, Inc. Recent Development
Table 35. GlaxoSmithKline plc Company Details
Table 36. GlaxoSmithKline plc Business Overview
Table 37. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 38. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 39. GlaxoSmithKline plc Recent Development
Table 40. Melinta Therapeutics, Inc. Company Details
Table 41. Melinta Therapeutics, Inc. Business Overview
Table 42. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 43. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 44. Melinta Therapeutics, Inc. Recent Development
Table 45. Debiopharm International S.A. Company Details
Table 46. Debiopharm International S.A. Business Overview
Table 47. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 48. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 49. Debiopharm International S.A. Recent Development
Table 50. MerLion Pharmaceuticals Pte Ltd. Company Details
Table 51. MerLion Pharmaceuticals Pte Ltd. Business Overview
Table 52. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 53. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 54. MerLion Pharmaceuticals Pte Ltd. Recent Development
Table 55. Durata Therapeutics, Inc. Company Details
Table 56. Durata Therapeutics, Inc. Business Overview
Table 57. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 58. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 59. Durata Therapeutics, Inc. Recent Development
Table 60. Paratek Pharmaceuticals, Inc. Company Details
Table 61. Paratek Pharmaceuticals, Inc. Business Overview
Table 62. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 63. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 64. Paratek Pharmaceuticals, Inc. Recent Development
Table 65. Cempra, Inc. Company Details
Table 66. Cempra, Inc. Business Overview
Table 67. Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 68. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 69. Cempra, Inc. Recent Development
Table 70. Abbott Laboratories, Inc. Company Details
Table 71. Abbott Laboratories, Inc. Business Overview
Table 72. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 73. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 74. Abbott Laboratories, Inc. Recent Development
Table 75. Actelion Pharmaceuticals Ltd. Company Details
Table 76. Actelion Pharmaceuticals Ltd. Business Overview
Table 77. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 78. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 79. Actelion Pharmaceuticals Ltd. Recent Development
Table 80. Albany Molecular Research, Inc. Company Details
Table 81. Albany Molecular Research, Inc. Business Overview
Table 82. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 83. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 84. Albany Molecular Research, Inc. Recent Development
Table 85. Allergan plc. Company Details
Table 86. Allergan plc. Business Overview
Table 87. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 88. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 89. Allergan plc. Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 93. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Bayer AG Company Details
Table 96. Bayer AG Business Overview
Table 97. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 98. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 99. Bayer AG Recent Development
Table 100. Macrolide Pharmaceuticals, Inc. Company Details
Table 101. Macrolide Pharmaceuticals, Inc. Business Overview
Table 102. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 103. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 104. Macrolide Pharmaceuticals, Inc. Recent Development
Table 105. Merck & Co, Inc. Company Details
Table 106. Merck & Co, Inc. Business Overview
Table 107. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 108. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 109. Merck & Co, Inc. Recent Development
Table 110. Pfizer, Inc. Company Details
Table 111. Pfizer, Inc. Business Overview
Table 112. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 113. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 114. Pfizer, Inc. Recent Development
Table 115. Sanofi Company Details
Table 116. Sanofi Business Overview
Table 117. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 118. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 119. Sanofi Recent Development
Table 120. Teva Pharmaceuticals Industries Ltd. Company Details
Table 121. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 122. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 123. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 124. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 125. Zavante Therapeutics, Inc. Company Details
Table 126. Zavante Therapeutics, Inc. Business Overview
Table 127. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 128. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022) & (US$ Million)
Table 129. Zavante Therapeutics, Inc. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Picture
Figure 2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share in Global 2017-2028
Figure 7. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered
Figure 8. Product Picture of Delafloxacin
Figure 9. Product Picture of Vancomycin
Figure 10. Product Picture of Ceftaroline Fosamil
Figure 11. Product Picture of Others
Figure 12. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type in 2022 & 2028
Figure 13. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2017-2028)
Figure 15. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type in 2022 & 2028
Figure 16. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 17. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2017-2028)
Figure 18. Product Picture of Cellulitis
Figure 19. Product Picture of Abscess
Figure 20. Product Picture of Surgical Wounds
Figure 21. Product Picture of Traumatic Wound
Figure 22. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application in 2022 & 2028
Figure 23. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 24. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2017-2028)
Figure 25. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application in 2022 & 2028
Figure 26. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 27. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2017-2028)
Figure 28. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. U.S. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 38. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Taiwan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Indonesia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Thailand Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Malaysia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Philippines Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 49. Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Argentina Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 53. Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. U.A.E Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 56. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 57. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 58. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 59. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 60. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 61. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 62. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 63. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 64. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 65. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 66. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 67. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 68. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 69. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 70. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 71. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 72. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 73. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 74. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 75. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Furiex Pharmaceuticals, Inc. GlaxoSmithKline plc Melinta Therapeutics, Inc. Debiopharm International S.A. MerLion Pharmaceuticals Pte Ltd. Durata Therapeutics, Inc. Paratek Pharmaceuticals, Inc. Cempra, Inc. Abbott Laboratories, Inc. Actelion Pharmaceuticals Ltd. Albany Molecular Research, Inc. Allergan plc. AstraZeneca Bayer AG Macrolide Pharmaceuticals, Inc. Merck & Co, Inc. Pfizer, Inc. Sanofi Teva Pharmaceuticals Industries Ltd. Zavante Therapeutics, Inc.